Serial #79432053
LIVE

Serial Number

79432053

Owner

TREEFROG THERAPEUTICS

Attorney

Rebeccah Gan

Filing Date

Jun 20, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79432053 Trademark

Serial Number: 79432053

Serial #79432053 is a trademark filed by TREEFROG THERAPEUTICS on June 20, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

TREEFROG THERAPEUTICS (11 trademarks)

30 Avenue Gustave Eiffel, Bâtiment A

Entity Type: 34

Trademark Details

Filing Date

June 20, 2025

Registration Date

Not Registered

Goods & Services

Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; scientific research on the differentiation of pluripotent stem cells into differentiated cells; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnology; software development in the field of biotechnology and cell therapy; research on controlling the quality of the production of cells by encapsulation; research on controlling the quality of cell therapy production

Scientific apparatus, namely, cytometers and biomimetic 3D culture systems composed of cell culture dishes for cell culture systems; scientific apparatus, namely, laboratory pipettes and capsules for the analysis and sorting of cell culture; bioreactors for cell culture; observation apparatus, namely, microscopes for cell culture; incubators for cell culture; cell culture apparatus for laboratory use, namely, cell culture dishes and tissue culture flaks; downloadable software used for the collection, analysis, sorting, communication of biological information relating to stem cells; measuring apparatus for controlling the quality of cell production by encapsulation; cell or molecule encapsulated lines being cell encapsulation apparatus for laboratory use, for the microencapsulation, culture and large-scale production of stem cells; microscopes; microfluidic systems being System on a chip (SoC) for parallelizing chips; microfluidic chip connectors being connectors for microfluidic devices used in cell culture and analysis

Pharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases, viral diseases, namely, HIV (Human Immunodeficiency Virus), HTLV-1 (Human T-lymphotropic Virus Type 1), Hepatitis B, Hepatitis C, Epstein-Barr Virus, Cytomegalovirus, SARS-CoV-2, Varicella-Zoster Virus, Herpes Simplex Virus, Measles Virus, autoimmune diseases, namely, Type 1 Diabetes, Multiple Sclerosis, Hashimoto's Thyroiditis, Rheumatoid Arthritis, Psoriasis, Systemic Lupus Erythematosus, Graves' Disease, Dermatitis, Allergic Eczema, immunodeficiency syndromes, cancers, inflammatory diseases, namely, Psoriasis, Atopic Dermatitis, Eczema, Crohn's Disease, Ulcerative Colitis, Asthma, Ankylosing Spondylitis, Macrophage Activation Syndrome, Hemophagocytic Lymphohistiocytosis; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases, viral diseases, namely, HIV (Human Immunodeficiency Virus), HTLV-1 (Human T-lymphotropic Virus Type 1), Hepatitis B, Hepatitis C, Epstein-Barr Virus, Cytomegalovirus, SARS-CoV-2, Varicella-Zoster Virus, Herpes Simplex Virus, Measles Virus, autoimmune diseases, namely, Type 1 Diabetes, Multiple Sclerosis, Hashimoto's Thyroiditis, Rheumatoid Arthritis, Psoriasis, Systemic Lupus Erythematosus, Graves' Disease, Dermatitis, Allergic Eczema, immunodeficiency syndromes, cancers, inflammatory diseases, namely, Psoriasis, Atopic Dermatitis, Eczema, Crohn's Disease, Ulcerative Colitis, Asthma, Ankylosing Spondylitis, Macrophage Activation Syndrome, Hemophagocytic Lymphohistiocytosis; pharmaceutical preparations for tissue regeneration; stem cells for medical or veterinary use; pluripotent stem cells intended for cell and gene therapies; cell culture media for medical or veterinary use; surgical implants comprised of living tissues obtained from stem cells; cell growth media for growing cells for medical use; culture matrices for medical or veterinary use; micro-tissues for use in reducing inflammation, regenerating and replacing cells, tissues and organs

Stem cells for research; stem cells for scientific purposes; nutrition agents, namely, cell culture reagents for scientific and research use for processing living cells other than for medical purposes; cell culture media other than for medical purposes; delivery media for scientific and research use for the delivery of cells cultures other than for medical purposes; micro-tissues obtained from stem cells for research purposes; cell aggregates for research; culture matrix being cell culture media for scientific research purposes

Apparatus for stem cell regeneration for medical use; apparatus for cell culture systems for medical purposes, namely, cell culture chambers and capsules; apparatus for cell culture systems by encapsulation for medical purposes; apparatus for analyzing and sorting cell culture for medical purposes, namely, cell culture chambers and capsules

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2026 TROA
LIMITATION OF GOODS RECEIVED FROM IB
Mar 19, 2026 LIMG
REFUSAL PROCESSED BY IB
Jan 8, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 19, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 18, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 11, 2025 RFCR
NON-FINAL ACTION WRITTEN
Nov 10, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 12, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 4, 2025 REPR